- Home
- CLSD vs NCRA Comparison
CLSD vs NCRA Comparison
Compare CLSD & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- NCRA
- Stock Information
- Founded
- CLSD 2011
- NCRA 2002
- Country
- CLSD United States
- NCRA Taiwan
- Employees
- CLSD N/A
- NCRA N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- CLSD Health Care
- NCRA Consumer Staples
- Exchange
- CLSD Nasdaq
- NCRA Nasdaq
- Market Cap
- CLSD 20.4M
- NCRA 23.0M
- IPO Year
- CLSD 2016
- NCRA N/A
- Fundamental
- Price
- CLSD $3.68
- NCRA $1.64
- Analyst Decision
- CLSD Hold
- NCRA
- Analyst Count
- CLSD 4
- NCRA 0
- Target Price
- CLSD $65.00
- NCRA N/A
- AVG Volume (30 Days)
- CLSD 29.9K
- NCRA 109.1K
- Earning Date
- CLSD 11-07-2025
- NCRA 11-13-2025
- Dividend Yield
- CLSD N/A
- NCRA N/A
- EPS Growth
- CLSD N/A
- NCRA N/A
- EPS
- CLSD N/A
- NCRA N/A
- Revenue
- CLSD $4,166,000.00
- NCRA $13,865,984.00
- Revenue This Year
- CLSD $98.20
- NCRA N/A
- Revenue Next Year
- CLSD $213.77
- NCRA N/A
- P/E Ratio
- CLSD N/A
- NCRA N/A
- Revenue Growth
- CLSD N/A
- NCRA N/A
- 52 Week Low
- CLSD $3.32
- NCRA $0.70
- 52 Week High
- CLSD $17.40
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- CLSD 51.21
- NCRA 51.12
- Support Level
- CLSD $3.68
- NCRA $1.56
- Resistance Level
- CLSD $4.08
- NCRA $1.71
- Average True Range (ATR)
- CLSD 0.26
- NCRA 0.08
- MACD
- CLSD -0.13
- NCRA -0.01
- Stochastic Oscillator
- CLSD 2.86
- NCRA 49.97
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.